Contact us for free information or to start a free case review.
After disclosures alerting the Food and Drug Administration that the pharmaceutical industry has been paying millions of dollars to physicians, the FDA is seeking to exclude scientists with substantial financial ties to medical device and drug companies from participating in the drug approval process.
Consumer advocates and congressional critics have sought to reduce or remove the involvement of doctors, scientists, and researchers who receive funding from drug companies from participating in FDA panels that make decisions about those companies’ products.
The policies would take effect later in the year.
Ramifications
The FDA’s deputy commissioner for policy, Randall Lutter, said, the proposal “strikes an appropriate balance” between the FDA’s need to employ experts and of ensuring that the public has faith in FDA decisions.
Researchers that receive lesser funds from the drug companies would still be able to participate in debates and attend meetings, but they would be prohibited from voting on advisory panels.
The proposal would disqualify about one-fourth of current FDA advisors from voting on the panels.
Peter Lurie, deputy director of Public Citizen’s health research group said that the change would ultimately be better for the patients because it would force the FDA to seek out scientists with no industry bias and result in “panels that are less tainted and recommendations that are more respected.”
Limitations
The bill proposes to limit doctors and researchers who have received $50,000 or more in research funding from companies with a financial stake in the FDA’s decisions. This $50,000 cap would also include stock values.
“It’s not perfect. The $50,000 is still too high,” said New York representative Maurice Hinchey, but he said it was a good first step.
Harmed by a dangerous or defective drug? Please contact us today for a complimentary consultation with an experienced and effective defective drug attorney who can help you recover the compensation you may be entitled to.
Copyright © 2001 - 2012 Online Lawyer Source
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.